Who is sponsoring NCT04075656?

NCT04075656 is sponsored by Emory University.

What condition does NCT04075656 study?

NCT04075656 studies Idiopathic Nephrotic Syndrome.

What drugs are being tested in NCT04075656?

Interventions: Standard of Care, UrApp.

What is the status of NCT04075656?

NCT04075656 is currently COMPLETED.

Last reviewed 2025-11-06 · How we verify

UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort)

NCT04075656 NA COMPLETED Results posted

Idiopathic nephrotic syndrome is one of the most common chronic kidney diseases in children. Patients suffer from frequent disease relapses and complications. Self-management is difficult for families and nonadherence is common, with adverse effects on the children's health. UrApp is a mobile application designed to assist families with nephrotic syndrome management. This study will examine whether providing the children's caregivers (or adolescent patients) with UrApp improves self-management and disease outcomes. This study will include 60 caregivers of children with newly diagnosed nephrotic syndrome. Participants will be randomized 1:1 to UrApp or standard of care and followed for 1 year.

Details

Lead sponsor	Emory University
Phase	NA
Status	COMPLETED
Enrolment	58
Start date	Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Apr 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Idiopathic Nephrotic Syndrome

Interventions

Standard of Care
UrApp

Countries

United States